CoChat

Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease

Sadleir, Katherine R., Eimer, William A., Kaufman, Randal J., Osten, Pavel, Vassar, Robert · 2014 · PLoS ONE
Cited by 36

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0101643

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. WL Klein, 2004, Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer’s disease, Neurobiol Aging, 25, 569, 10.1016/j.neurobiolaging.2004.02.010 · DOI · Paper page
  2. SH Yun, 2006, Amyloid-beta1–42 reduces neuronal excitability in mouse dentate gyrus, Neurosci Lett, 403, 162, 10.1016/j.neulet.2006.04.065 · DOI
  3. Akram A, Christoffel D, Rocher AB, Bouras C, Kovari E, et al. (2007) Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer’s disease. Neurobiol Aging. · DOI
  4. B Calabrese, 2007, Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein, Mol Cell Neurosci, 35, 183, 10.1016/j.mcn.2007.02.006 · DOI · Paper page
  5. H Zempel, 2012, Linking Amyloid-beta and Tau: Amyloid-beta Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton, Neurodegener Dis, 10, 64, 10.1159/000332816 · DOI · Paper page
  6. A Rovelet-Lecrux, 2006, APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nat Genet, 38, 24, 10.1038/ng1718 · DOI · Paper page
  7. K Sleegers, 2006, APP duplication is sufficient to cause early onset Alzheimer’s dementia with cerebral amyloid angiopathy, Brain, 129, 2977, 10.1093/brain/awl203 · DOI · Paper page
  8. J Hardy, 2002, The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  9. H Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch Neurol, 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  10. R Li, 2004, Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients, Proc Natl Acad Sci U S A, 101, 3632, 10.1073/pnas.0205689101 · DOI · Paper page
  11. T O’Connor, 2008, Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis, Neuron, 60, 988, 10.1016/j.neuron.2008.10.047 · DOI · Paper page
  12. SJ Tyler, 2002, alpha- and beta-secretase: profound changes in Alzheimer’s disease, Biochem Biophys Res Commun, 299, 373, 10.1016/S0006-291X(02)02635-9 · DOI · Paper page
  13. KR Sadleir, 2012, Cdk5 protein inhibition and Abeta42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease, J Biol Chem, 287, 7224, 10.1074/jbc.M111.333914 · DOI · Paper page
  14. Y Wen, 2004, Increased beta-secretase activity and expression in rats following transient cerebral ischemia, Brain Res, 1009, 1, 10.1016/j.brainres.2003.09.086 · DOI · Paper page
  15. Y Tong, 2005, Oxidative stress potentiates BACE1 gene expression and Abeta generation, J Neural Transm, 112, 455, 10.1007/s00702-004-0255-3 · DOI · Paper page
  16. I Blasko, 2004, Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer’s disease beta-secretase (BACE-1), J Neural Transm, 111, 523, 10.1007/s00702-003-0095-6 · DOI · Paper page
  17. Y Wen, 2008, Transcriptional Regulation of beta-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing, Neuron, 57, 680, 10.1016/j.neuron.2008.02.024 · DOI · Paper page
  18. V Boissonneault, 2009, MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1, J Biol Chem, 284, 1971, 10.1074/jbc.M807530200 · DOI · Paper page
  19. MA Faghihi, 2010, Evidence for natural antisense transcript-mediated inhibition of microRNA function, Genome Biol, 11, R56, 10.1186/gb-2010-11-5-r56 · DOI · Paper page
  20. WX Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1, J Neurosci, 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
  21. Y Zong, 2011, miR-29c regulates BACE1 protein expression, Brain Res, 1395, 108, 10.1016/j.brainres.2011.04.035 · DOI · Paper page
  22. D De Pietri Tonelli, 2004, Translational regulation of BACE-1 expression in neuronal and non-neuronal cells, Nucleic Acids Res, 32, 1808, 10.1093/nar/gkh348 · DOI · Paper page
  23. S Lammich, 2004, Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region, EMBO Rep, 5, 620, 10.1038/sj.embor.7400166 · DOI
  24. M Mihailovich, 2007, Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5′ untranslated region, Nucleic Acids Res, 35, 2975, 10.1093/nar/gkm191 · DOI · Paper page
  25. GW Rogers Jr, 2004, Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation, Proc Natl Acad Sci U S A, 101, 2794, 10.1073/pnas.0308576101 · DOI · Paper page
  26. D Scheuner, 2001, Translational control is required for the unfolded protein response and in vivo glucose homeostasis, Mol Cell, 7, 1165, 10.1016/S1097-2765(01)00265-9 · DOI · Paper page
  27. CS Chan, 2011, HCN channelopathy in external globus pallidus neurons in models of Parkinson’s disease, Nat Neurosci, 14, 85, 10.1038/nn.2692 · DOI · Paper page
  28. Y Levites, 2006, Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice, J Neurosci, 26, 11923, 10.1523/JNEUROSCI.2795-06.2006 · DOI · Paper page
  29. Sorensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, et al. (2008) NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus. · DOI
  30. JP Mayginnes, 2006, Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR, J Virol Methods, 137, 193, 10.1016/j.jviromet.2006.06.011 · DOI
  31. SE Reed, 2006, Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors, J Virol Methods, 138, 85, 10.1016/j.jviromet.2006.07.024 · DOI · Paper page
  32. KR Patterson, 2011, Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease, J Biol Chem, 286, 23063, 10.1074/jbc.M111.237974 · DOI · Paper page
  33. I Novoa, 2001, Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha, J Cell Biol, 153, 1011, 10.1083/jcb.153.5.1011 · DOI · Paper page
  34. B He, 1996, The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1) 34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells, J Virol, 70, 84, 10.1128/JVI.70.1.84-90.1996 · DOI
  35. A Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease, Nature, 349, 704, 10.1038/349704a0 · DOI · Paper page
  36. R Sherrington, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease, Nature, 375, 754, 10.1038/375754a0 · DOI · Paper page
  37. J Chu, 2012, Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice, Mol Neurodegener, 7, 1, 10.1186/1750-1326-7-1 · DOI
  38. L Devi, 2013, Deletion of the eIF2alpha Kinase GCN2 fails to rescue the memory decline associated with Alzheimer’s disease, PLoS One, 8, e77335, 10.1371/journal.pone.0077335 · DOI · Paper page
  39. L Devi, 2013, Mechanisms that lessen benefits of beta-secretase reduction in a mouse model of Alzheimer’s disease, Transl Psychiatry, 3, e284, 10.1038/tp.2013.59 · DOI · Paper page
  40. T Ma, 2013, Suppression of eIF2alpha kinases alleviates Alzheimer’s disease-related plasticity and memory deficits, Nat Neurosci, 16, 1299, 10.1038/nn.3486 · DOI · Paper page

Cited by

See all 36

Metadata

Authors
Sadleir, K. R., Eimer, W. A., Kaufman, R. J., Osten, P., & Vassar, R.
Venue
PLoS ONE
Published
2014-07-03
Volume
9
Issue
7
Pages
e101643
ISSN
1932-6203
Cited by
36
References
32
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.